Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil versus sufentanil for early recovery after laparoscopic hernia repair
ChiCTR1900027245Phase 4Not yet recruiting
- Sponsor
- Xuzhou Traditional Chinese Medicine Hospital
- Start
- Jan 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remifentanil and sufentanil in hernia (2 arms), sponsored by Xuzhou Traditional Chinese Medicine Hospital. Primary endpoint: QoR-15 score. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
remifentanilsufentanil
03
Conditions
hernia
Beyond the preview
Go deeper on ChiCTR1900027245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027245.